Triple
T36600562
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | APHINITY |
E902901
|
entity |
| Predicate | keyFinding |
P42880
|
FINISHED |
| Object | benefit of pertuzumab was more pronounced in higher-risk subgroups such as node-positive disease |
—
|
LITERAL FINISHED |
Provenance (2 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69f76e66b7b88190848f7a3e1188915f |
elicitation | completed |
| NER | batch_69f7c30c8a0c819080129402f7c3f0c8 |
ner | completed |
Created at: May 3, 2026, 4:11 p.m.